Toasted Tobacco E Liquid

Feellife Tobacco: We know not everyone wants to shop for e-liquid by range, some people have their favourite flavour profile and they want to stick to it, so we have made it easy for you to stock up on your favourites. Big flavours that pack a punch, you will feel like you have stepped into the...
Chat Now

Product Details

Feellife Tobacco: We know not everyone wants to shop for e-liquid by range, some people have their favourite flavour profile and they want to stick to it, so we have made it easy for you to stock up on your favourites.

Big flavours that pack a punch, you will feel like you have stepped into the world’s best tobacconist with our outstanding range of Tobacco flavours. Earthy, nutty, aromatic or with a hint of caramel your tobacco tastes are catered for here, indulge your opulent side today.

Need help picking your next all day vape? Why not get real time advice with our live chat, just look in the bottom right hand corner of your screen.

Capacity: 10ml,15ml, 30ml, 60ml, 120ml

Nicotine Strength: 0mg/g, 8mg/g, 12mg/g, 18mg/g, 24mg/g

Ingredients: Herbal extract/Glycerol/ Propylene glycol/Flavorings/Nicotine

Bottle type: Child proof cap

Package: top-grade plastic package

Certificates: TUV, MSDS, JRFL, ISO, FDA, GMP, SGS





FEELLIFE CLASSIC SERIES

We want to create the best e-Liquids possible. Here is our classic CLASSIC SERIES Range: the finest, premium quality, all-natural and pharmaceutically approved ingredients. This is the reason why we are known worldwide for our first-class products.

All e-Liquids undergo independent quality control and are GCC and TPD compliant, with many international certificates. Our production line uses only high-quality and environmentally friendly ingredients. In order to encompass the best flavours possible, we obtain from raw fruit extracts and genuine tobacco extracts. The ingredients used in our products promote the precise taste and natural elements which is to define our Silver Label flavours.


CLASSIC SERIES FEATURES:

Feellife uses only high-quality and environment-friendly ingredients that are free of harmful substances.

• Molecular technology secures natural extracts

• High-quality pharmaceutical grade solvents

• Natural flavour extracts

• Fully TPD Compliant

• Huge range of flavours


Notes:

Not suitable for anyone under 18, pregnant or breast feeding women. Keep locked up and out of the reach of children, always keep in a cool, dry and dark place. Avoid contact with skin and eyes, in case of contact rinse with plenty of water. If swallowed, seek medical advice immediately (show the label where possible


THE HIGHEST STANDARDS

 We’ve invested in the highest-grade packaging to make sure that our liquids are delivered in a safe manner. Our bottles are filled at a pharmaceutical-grade facility, our bottle caps meet national standards for child resistance, and each bottle is individually shrink-wrapped to prevent leakage in transport. We think it’s important to make sure that you get every drop safely and securely to enhance your vaping experiences.


FEELLIFE INTRODUCTION

Since set up in 2009, FEELLiFE has focused on the research and development and production of e-liquid, rapidly developed into the top global e-liquid OEM manufacturer, providing high-quality e-liquid products for many well-known e-liquid brands all over the world.

With modern international standard factory, pharmaceutical grade dust-free workshop and assembly line, FEELLiFE make sure every bottle of e-liquid to meet the requirements of high quality.

image002

Factory Address: 202 North California Ave, City of Industry CA 91744 U.S.A.


China factory

image014(001).jpg


Exhibition

image016_副本.jpg

image017_副本.jpg

image005

image018_副本.jpg

image019_副本.jpg

image020_副本.jpg

image010


Industry News

Eliminate Vaping Restrictions, Urges U.K. Parliament Committee 

image011

A committee of the U.K. Parliament has issued a report endorsing the promotion of e-cigarettes to smokers, and calling for review of some vaping products restrictions. The report also rejects the idea that vaping acts as a gateway to smoking among British youth.

The committee concludes that U.K. lawmakers and regulators should not treat vapor products the same as combustible cigarettes.

The report, from the House of Commons Science and Technology Committee, follows months of testimony from public health and scientific experts, and representatives from tobacco control organizations, and the vaping industry and consumer community. The committee is chaired by MP Norman Lamb of North Norfolk.


The specific recommendations from the committee are:

• Encourage a wider debate about vaping in public places

• Continue to annually review the evidence on e-cigarettes, and extend the review to heat-not-burn products

• Institute a long-term research program overseen by Public Health England and the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment

• Review the 20 mg/mL limit on e-liquid nicotine strength

• Review the 2 mL limit on tank size

• Review the prohibition on making health claims for the relative health benefits of vaping versus smoking

• Regulations, advertising rules, and taxes should “reflect the evidence of the relative harms of the various e-cigarettes, heat-not-burn and tobacco products available”

• The National Health Service (NHS) should allow vaping in mental health facilities as a default policy

• The government should review the evidence supporting the current ban on snus


Some of the recommendations can’t be acted upon until the U.K. leaves the European Union, since the rules are part of the EU’s Tobacco Products Directive (TPD). The nicotine strength and tank size limits, and the advertising restrictions are all mandated by the TPD. The snus ban is also part of EU tobacco regulations. (Snus is Swedish smokeless tobacco that has been shown to carry no discernible risk.)

Last year’s official English tobacco control plan also urged reconsideration of some of the TPD-mandated restrictions on vaping products. But that plan only includes England, not the rest of the U.K. (which also includes Scotland, Wales, and Northern Ireland).


The report urges a more efficient process for licensing medical e-cigarettes, which some in the vaping community have viewed skeptically, seeing pharmaceutical e-cigs as a threat to the consumer vaping market. Of course, they may also just be another option for smokers — and one that doctors might embrace more readily.

The committee also recognizes that mentally ill people smoke at much higher rates than the general public, and should benefit from the lower risk of vaping to themselves and bystanders. Many NHS hospitals currently ban smoking and vaping on their grounds.


“The percentage of people smoking among those with mental health conditions remains stubbornly high, while it is declining in the general population,” said committee chair Norman Lamb. “People with mental health conditions are almost 2.5 times more likely to smoke compared to the general population. It is therefore extraordinary that one-third of mental health trusts ban the use of e-cigarettes completely, while three-quarters of NHS trusts are mistakenly concerned about ‘second-hand’ e-cigarette vapour.

“This is unacceptable,” Lamb noted. “Those with mental ill health are being badly let down and NHS England appear to have failed to give this any priority. NHS England’s default policy should be that e-cigarettes should be permitted in mental health units.”


The New Nicotine Alliance (NNA) welcomed the report. Britain’s most prominent consumer advocacy organization issued a statement praising the committee report for its “evidence-based policy proposals which would positively transform the way vaping is viewed by businesses, institutions and the public alike.”

“E-cigarettes are a proven safer alternative to smoking and the UK boasts 1.5 million former smokers who have converted from combustible tobacco to exclusively vaping instead,” said NNA chair Sarah Jakes. “The Science and Technology Committee has wisely recognised that misconceptions about e-cigarettes are threatening further progress in encouraging their use by smokers who choose to quit.”


“We welcome the Committee’s call for a root and branch review of how risk-reduced products are treated by businesses, institutions and government itself. The report is a beacon of enlightenment in an area of public health which is often burdened by dogma and outdated thinking towards the use of nicotine.

“There is a lot of confusion about e-cigarettes amongst the public, health institutions and businesses”, Jakes noted. “This report is therefore timely and could have hugely positive implications for public health if its recommendations are implemented in full. Sir Norman’s committee has done an excellent job of peering through the mist of misunderstanding surrounding e-cigarettes and its policy proposals can go a long way to dispel the – often deliberately fabricated – misconceptions that are deterring many thousands of smokers from switching.

“We would urge the government to read the Committee’s findings carefully and act on them without delay.”


from vaping360.com

Post time: Aug-31-2018


Inquiry